IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (25)
J P Morgan Chase
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 7 | Quanterix Corpo | Capital-Goods | 15 | 4 | JPM | LRNK | 54.9% | 16.5% | |||
Nov 17 | Stitch Fix Inc. | Consumer-Services | 15 | 8 | GS | JPM | 128.9% | 1% | |||
Nov 2 | Evoqua Water Te | Technology | 18 | 27 | CS | JPM | RBC | 51.3% | 16% | ||
Nov 2 | Funko Inc. | Consumer-Non-Durables | 12 | 10 | GS | JPM | BAML | 93.9% | -41.1% | ||
Nov 1 | Altair Engineer | Technology | 13 | 12 | JPM | RBC | DB | 62.8% | 40.8% | ||
Oct 27 | Nexa Resources | Basic-Industries | 16 | 31 | JPM | BMO | MS | 19.9% | 8.7% | ||
Oct 5 | Five Point Hold | Finance | 14 | 21 | CITI | JPM | 26.1% | 7.4% | |||
Sep 28 | Deciphera Pharm | Health-Care | 17 | 7 | JPM | PPRJ | 77.2% | 3.8% | |||
Sep 20 | Zai Lab Limited | Health-Care | 18 | 8 | JPM | CITI | LRNK | 60.6% | 55.2% | ||
Aug 12 | Denali Therapeu | Health-Care | 18 | 13 | GS | MS | JPM | 28.1% | 19.2% | ||
Jul 20 | Kala Pharmaceut | Health-Care | 15 | 6 | JPM | BAML | 65.4% | 23.3% | |||
Jun 28 | Mersana Therape | Health-Care | 15 | 5 | JPM | COWN | LRNK | 54% | -6.7% | ||
Jun 22 | Altice USA Inc. | Consumer-Services | 30 | 63 | JPM | MS | CITI | 49.2% | 9% | ||
Jun 22 | Safety Income & | Consumer-Services | 20 | 10 | BAML | JPM | BRCL | 31.3% | -5% | ||
Jun 14 | Athenex Inc. | Health-Care | 11 | 6 | CS | DB | JPM | 32.5% | 14.2% | ||
Jun 10 | Switch Inc. | Technology | 17 | 31 | GS | JPM | BMO | 142.3% | 22.6% | ||
May 17 | G1 Therapeutics | Health-Care | 15 | 7 | JPM | COWN | 38.7% | 0% | |||
Apr 13 | Cadence Bancorp | Finance | 20 | 7 | GS | JPM | 71.9% | 7.8% | |||
Apr 13 | Yext Inc. | Technology | 11 | 10 | MS | JPM | RBC | 108% | 21.9% | ||
Mar 24 | Alteryx Inc. | Technology | 14 | 9 | GS | JPM | CITI | 96.2% | 10.7% | ||
Jan 27 | JELD-WEN Holdin | Basic-Industries | 23 | 25 | BRCL | JPM | CITI | 64.1% | 13.6% | ||
Jan 27 | Jounce Therapeu | Health-Care | 16 | 6 | JPM | COWN | 66% | 7.8% | |||
Jan 3 | Hamilton Lane I | Finance | 16 | 11 | JPM | MS | 60.2% | 12.6% | |||
Jan 2 | Invitation Home | Finance | 20 | 77 | JPM | BAML | MS | 40% | 0% | ||
Jan 2 | Laureate Educat | Consumer-Services | 14 | 35 | MS | JPM | GS | 30.6% | -5.4% |
*
Lead manager or one of top three managers in an underwriting team.